(PharmaNewsWire.Com, February 26, 2018 ) The Global Contrast Media Market is worth USD 4.3 Billion in 2016 and estimated to grow at a CAGR of 4.6%, to reach USD 5.38 billion by 2021.
Contrast Media market Drivers and Restraints:
The Global Contrast Media Market is developing at an exceptionally quick pace. Contrast media used as a part of therapeutic imaging are grouped on the premise of imaging modalities. The two most normally utilized contrast media are iodine-containing contrast medium and gadolinium contrast medium. The shade of structures in the body changes when pictures are caught with contrast media in the body. The delicate tissues are viewed as dim, while the bones look light dark. The contrast media enhances the contrast between various parts of the body and classifies between various parts of the body that have comparative pieces. The market for Contrast Media is required to witness noteworthy development amid the estimate forecast period because of rising in the number of aging population, growing research and development activities in the field of imaging modalities, demand image-guided techniques, an increase in the incidence of chronic diseases. However adverse reactions of contrast media on the body and huge costs involved limit the growth of the market.
The Global Contrast Media Market is segmented on the basis of procedure, application, and route of administration, indication, type, and region. Based on the procedure, the market is segmented into X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound. The ultrasound segment is likely to have the highest CAGR during the given forecast period. Development of micro bubble contrast media for an ultrasound, a large number of approvals for ultrasound contrast media in the U.S., Europe, and Japan are some of the major factors driving the growth of this segment.
Based on application, the market is segmented into Radiology, Interventional Radiology, and Interventional Cardiology. Based on the route of administration, the market is segmented into Oral Contrast Media, Injectable Contrast Media, Rectal Contrast Media, Urethral Contrast Media. Based on an indication, the market is segmented into Cardiovascular Disorders, Oncology, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders. Based on the type, the market is segmented into Barium-Based Contrast Media, Iodinated Contrast Media, Gadolinium-Based Contrast Media, and Micro bubble Contrast Media.
Geographically, the Contrast Media market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East Asia. North America is estimated to constitute the largest share of this market, while the Asia Pacific region is expected to witness the fastest growth and overtake North America, being the second largest shareholder for the market during the forecast period.
CMC Contrast AB (Sweden), Daiichi Sankyo (Japan), Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy) in 2015. Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany), and Subhra Pharma Private Limited (India).are the leaders in the global Contrast Media market.
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
